Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

With Latest Round Of Cuts, China Continues March To Narrow Gap Between Big Pharma And Local Generics

This article was originally published in PharmAsia News

Executive Summary

SHANGHAI - As expected, China's powerful National Development and Reform Commission announced Aug. 5 a new round of price cuts, this time targeting hormone and endocrinology drugs and central nervous system drugs, with an average cut of roughly 14%, according to analysts

You may also be interested in...



Sanofi Sees China Growth Bolstered By County Hospitals Push

Thousands of county hospitals offer significant growth opportunities for the next 10 years, says Sanofi SVP Jean-Luc Lowinski, but adds the challenges at building the market are unique for multinational drug manufacturers in China.

Asia Spotlight: GSK’s Lamictal, Sanofi’s Lantus Among Latest Round Of China Price Cuts

China’s NDRC cuts retail ceiling prices on more than 700 formulations of 400 drugs across 20 therapeutic areas, targeting newer products.

GSK’s Lamictal, Sanofi’s Lantus Among Latest Round Of China Price Cuts

China’s NDRC cuts retail ceiling prices on more than 700 formulations of 400 drugs across 20 therapeutic areas, targeting newer products.

Related Content

UsernamePublicRestriction

Register

LL026487

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel